Current Report Filing (8-k)
June 03 2016 - 4:22PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 2, 2016
Commission File Number: 0-24260
Amedisys, Inc.
(Exact name of registrant as specified in charter)
|
|
|
|
|
Delaware
|
|
11-3131700
|
|
(State or other jurisdiction
|
|
(IRS Employer
|
|
of incorporation or organization)
|
|
Identification No.)
|
3854 American Way, Suite A, Baton Rouge, LA 70816
(Address of principal executive offices, including zip code)
(225) 292-2031 or (800) 467-2662
(Registrant’s telephone number, including area code)
5959 S. Sherwood Forest Blvd., Baton Rouge, LA 70816
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (
see
General Instruction A.2 below):
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.07. Submission of Matters to a Vote of Security Holders.
Amedisys, Inc. (the “Company”) held its annual meeting of stockholders on Thursday, June 2, 2016. At the annual meeting, the
Company’s stockholders voted on three proposals. A brief description of and tabulation of votes for each proposal are set forth below.
Proposal 1
. The Company’s stockholders elected the following ten directors for a term of one year. There were 1,777,311 broker
non-votes with respect to the proposal.
|
|
|
|
|
|
|
|
|
|
|
Nominee
|
|
For
|
|
|
Withheld
|
|
|
Linda J. Hall, PhD
|
|
|
29,112,781
|
|
|
|
132,473
|
|
|
Julie D. Klapstein
|
|
|
29,113,410
|
|
|
|
131,844
|
|
|
Paul B. Kusserow
|
|
|
29,081,934
|
|
|
|
163,320
|
|
|
Ronald A. LaBorde
|
|
|
27,810,323
|
|
|
|
1,434,931
|
|
|
Richard A. Lechleiter
|
|
|
29,110,319
|
|
|
|
134,935
|
|
|
Jake L. Netterville
|
|
|
29,052,463
|
|
|
|
192,791
|
|
|
Bruce D. Perkins
|
|
|
29,111,082
|
|
|
|
134,172
|
|
|
Jeffrey A. Rideout, MD
|
|
|
29,112,760
|
|
|
|
132,494
|
|
|
Donald A. Washburn
|
|
|
28,782,630
|
|
|
|
462,624
|
|
|
Nathaniel M. Zilkha
|
|
|
23,586,989
|
|
|
|
5,658,265
|
|
Proposal 2
. The Company’s stockholders ratified the selection of KPMG LLP as the Company’s
independent registered public accountants for the fiscal year ending December 31, 2016. There were no broker non-votes with respect to the proposal.
|
|
|
|
|
|
|
|
|
|
|
For
|
|
Against
|
|
|
Abstain
|
|
|
30,831,740
|
|
|
180,716
|
|
|
|
10,109
|
|
Proposal 3
. The Company’s stockholders approved, on an advisory (non-binding) basis, the
compensation paid to the Company’s named executive officers. There were 1,777,311 broker non-votes with respect to the proposal.
|
|
|
|
|
|
|
|
|
|
|
For
|
|
Against
|
|
|
Abstain
|
|
|
26,670,433
|
|
|
2,540,608
|
|
|
|
34,213
|
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
AMEDISYS, INC.
|
|
|
|
|
By:
|
|
/s/ Paul B. Kusserow
|
|
Paul B. Kusserow
President and
Chief Executive Officer
|
|
|
|
DATE: June 3, 2016
|
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Apr 2023 to Apr 2024
